Related Experiment Video
Updated: May 11, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Published on: June 4, 2012
Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline
George Sakoulas1, Poochit Nonejuie, Victor Nizet
1Department of Pediatric Pharmacology and Drug Discovery, University of California San Diego School of Medicine, La Jolla, California, USA. gsakoulas@ucsd.edu
Abstract:
A recurrent case of left-sided endocarditis caused by high-level aminoglycoside-resistant Enterococcus faecalis was successfully treated with ceftaroline and daptomycin. This combination demonstrated excellent synergy in vitro. Mechanistically, ceftaroline enhanced binding of daptomycin to the cell membrane and sensitized E. faecalis to killing by human cathelicidin LL-37, a cationic innate host defense peptide. Daptomycin plus ceftaroline may be considered in salvage therapy in E. faecalis endovascular infections and requires further study.
Related Concept Videos
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Clinical Significance of Antibiotic Resistance